{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:12:12Z","timestamp":1790824332399,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The COVID-19 pandemic has had a substantial and lasting impact on care provision, particularly in the field of cancer care. National steering has helped monitor the health situation and adapt the provision and organisation of care. Based on data from the French administrative healthcare database (SNDS) on the entire French population (67 million people), screening, diagnostic and therapeutic activity was monitored and compared 2019 on a monthly basis. A noteworthy decline in all activities (with the exception of chemotherapy) was observed during the first lockdown in France. Over the months that followed, this activity returned to normal but did not make up for the shortfall from the first lockdown. Finally, during the lockdown in late 2020, cancer care activity was conserved. In brief, in 2020, the number of mammograms decreased by 10% (\u2212\u2009492,500 procedures), digestive endoscopies by 19% (\u2212\u2009648,500), and cancer-related excision by 6% (\u2212\u200923,000 surgical procedures). Hospital radiotherapy activity was down 3.8% (\u2212\u20094400 patients) and that in private practice was down 1.4% (\u2212\u20091600 patients). Chemotherapy activity increased by 2.2% (7200 patients), however. To summarize,\u00a0COVID-19 had a very substantial impact during the first lockdown. Safeguarding cancer care activity helped limit this impact over the months that followed, but the situation remains uncertain. Further studies on the medium- and long-term impact on individuals (survival, recurrence, after-effects) will be conducted.<\/jats:p>","DOI":"10.1038\/s41598-022-07984-w","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:03:08Z","timestamp":1646913788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Monitoring the impact of COVID-19 in France on cancer care: a differentiated impact"],"prefix":"10.1038","volume":"12","author":[{"given":"Christine","family":"Le Bihan Benjamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien-Aymeric","family":"Simonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Khati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Houas-Bernat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"M\u00e9ric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe-Jean","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"7984_CR1","unstructured":"Institut national du cancer. Pr\u00e9conisations pour l\u2019adaptation de l\u2019offre de soins des \u00e9tablissements accueillantes patients atteints de cancer dans le contexte de l\u2019\u00e9pid\u00e9mie de COVID-19 Version 16 avril 2020. [Internet]. Institut national du cancer; 2020 [cit\u00e9 22 mars 2021]. Disponible sur: https:\/\/www.e-cancer.fr\/content\/download\/288948\/4112412\/file\/Preconisations%20pour%20l%E2%80%99adaptation%20de%20l%E2%80%99offre%20de%20soins%20des%20etablissements%20accueillant%20les%20patients%20atteints%20de%20cancer%20dans%20le%20contexte%20de%20l%E2%80%99epidemie%20de%20covid-19.pdf."},{"key":"7984_CR2","unstructured":"Institut national du cancer. Organisation de la consultation d\u2019annonce et place de l\u2019accompagnant dans le parcours du patient atteint de cancer. Version du 05 juin 2020 [Internet]. Institut national du cancer; 2020 [cit\u00e9 22 mars 2021]. Disponible sur: https:\/\/www.e-cancer.fr\/content\/download\/291573\/4152450\/file\/Fiche%20pratique%20cancer%20et%20COVID-19%20-%20Organisation%20de%20la%20consultation%20d%E2%80%99annonce%20et%20place%20de%20l%E2%80%99accompagnant%20dans%20le%20parcours%20du%20patient%20atteint%20de%20cancer.pdf."},{"key":"7984_CR3","unstructured":"Institut national du cancer. Organisation de la reprise d\u2019activit\u00e9 de chirurgie des cancers. Version du 8 juin 2020 [Internet]. Institut national du cancer; 2021 [cit\u00e9 22 mars 2021]. Disponible sur: https:\/\/www.e-cancer.fr\/content\/download\/291572\/4152440\/file\/Fiche%20pratique%20cancer%20et%20COVID-19%20-%20Organisation%20de%20la%20reprise%20d%E2%80%99activite%CC%81%20de%20chirurgie%20des%20cancers.pdf."},{"key":"7984_CR4","unstructured":"Institut national du cancer. Organisation du rattrapage et de la continuit\u00e9 de l\u2019activit\u00e9 de diagnostic et de traitement des cancers n\u00e9cessitant un plateau technique et des ressources en anesth\u00e9sie r\u00e9animation. Version du 15 d\u00e9cembre 2020 [Internet]. Institut national du cancer; 2020 [cit\u00e9 22 mars 2021]. Disponible sur: https:\/\/www.e-cancer.fr\/content\/download\/300077\/4279343\/file\/FICHE%20PRATIQUE%20Organisation%20du%20rattrapage%20et%20de%20la%20continuite%CC%81%20de%20l%E2%80%99activite%CC%81%20de%20diagnostic%20et%20de%20traitement%20des%20cancers%20ne%CC%81cessitant%20un%20plateau%20technique%20et%20des%20ressources%20en%20anesthe%CC%81sie-re%CC%81animation.pdf."},{"key":"7984_CR5","unstructured":"Institut national du cancer. Pr\u00e9conisations de priorisation des patients atteints de cancer pour la vaccination contre le SARS-CoV-2. [Internet]. Institut national du cancer; 2021 [cit\u00e9 22 mars 2021]. Disponible sur: https:\/\/www.e-cancer.fr\/content\/download\/288948\/4112412\/file\/Preconisations%20pour%20l%E2%80%99adaptation%20de%20l%E2%80%99offre%20de%20soins%20des%20etablissements%20accueillant%20les%20patients%20atteints%20de%20cancer%20dans%20le%20contexte%20de%20l%E2%80%99epidemie%20de%20covid-19.pdf."},{"key":"7984_CR6","unstructured":"Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9. Continuit\u00e9 des activit\u00e9s des Centres r\u00e9gionaux de coordination des d\u00e9pistages des cancers (CRCDC). Version du 3 avril 2020 [Internet]. Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9; 2020 [cit\u00e9 22 mars 2021]. Disponible sur: https:\/\/e-cancer.fr\/content\/download\/303523\/4330146\/version\/1\/file\/INCa_Avis_Ultra-priorisation_vaccin_covid_2021-01-26-Vdef.pdf."},{"issue":"6","key":"7984_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s43018-020-0074-y","volume":"1","author":"M Richards","year":"2020","unstructured":"Richards, M., Anderson, M., Carter, P., Ebert, B. L. & Mossialos, E. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer. 1(6), 565\u2013567 (2020).","journal-title":"Nat. Cancer."},{"key":"7984_CR8","unstructured":"National health system England. Cancer [Internet]. National health system England; [cit\u00e9 22 mars 2021]. Disponible sur: https:\/\/www.england.nhs.uk\/coronavirus\/cancer\/."},{"key":"7984_CR9","unstructured":"National institute of health. Special Considerations in Adults and Children With Cancer [Internet]. National institute of health; [cit\u00e9 22 mars 2021]. Disponible sur: https:\/\/www.covid19treatmentguidelines.nih.gov\/special-populations\/cancer\/."},{"issue":"6497","key":"7984_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1126\/science.abd3377","volume":"368","author":"NE Sharpless","year":"2020","unstructured":"Sharpless, N. E. COVID-19 and cancer. Science 368(6497), 1290\u20131290 (2020).","journal-title":"Science"},{"issue":"9","key":"7984_CR11","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/s41416-021-01261-9","volume":"124","author":"LM Kregting","year":"2021","unstructured":"Kregting, L. M. et al. Effects of cancer screening restart strategies after COVID-19 disruption. Br. J. Cancer. 124(9), 1516\u20131523 (2021).","journal-title":"Br. J. Cancer."},{"key":"7984_CR12","doi-asserted-by":"crossref","unstructured":"McBain RK, Cantor JH, Jena AB, Pera MF, Bravata DM, Whaley CM. Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic. J Gen Intern Med [Internet]. 19 mars 2021 [cit\u00e9 5 mai 2021]; Disponible sur: http:\/\/link.springer.com\/10.1007\/s11606-021-06660-5.","DOI":"10.1007\/s11606-021-06660-5"},{"issue":"8","key":"7984_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.annonc.2020.05.009","volume":"31","author":"A Sud","year":"2020","unstructured":"Sud, A. et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann. Oncol. 31(8), 1065\u20131074 (2020).","journal-title":"Ann. Oncol."},{"issue":"3","key":"7984_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ejso.2019.11.513","volume":"46","author":"F Grass","year":"2020","unstructured":"Grass, F. et al. Impact of delay to surgery on survival in stage I-III colon cancer. Eur J Surg Oncol. 46(3), 455\u2013461 (2020).","journal-title":"Eur J Surg Oncol."},{"key":"7984_CR15","doi-asserted-by":"publisher","first-page":"103273","DOI":"10.1016\/j.critrevonc.2021.103273","volume":"167","author":"M Boutros","year":"2021","unstructured":"Boutros, M., Moujaess, E. & Kourie, H. R. Cancer management during the COVID-19 pandemic: choosing between the devil and the deep blue sea. Crit. Rev. Oncol. Hematol. 167, 103273 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"Suppl 4","key":"7984_CR16","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","volume":"65","author":"P Tuppin","year":"2017","unstructured":"Tuppin, P. et al. Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France. Rev. Epidemiol. Sante Publ. 65(Suppl 4), S149\u2013S167 (2017).","journal-title":"Rev. Epidemiol. Sante Publ."},{"key":"7984_CR17","unstructured":"D\u00e9cret n\u00b02007-388 du 21 mars 2007 relatif aux conditions d\u2019implantation applicables \u00e0 l\u2019activit\u00e9 de soins de traitement du cancer. mars 21, (2007)."},{"key":"7984_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1200\/CCI.20.00134","volume":"4","author":"D Patt","year":"2020","unstructured":"Patt, D. et al. Impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American Seniors. JCO Clin. Cancer Inform. 4, 1059\u20131071 (2020).","journal-title":"JCO Clin. Cancer Inform."},{"issue":"7","key":"7984_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jacr.2020.05.004","volume":"17","author":"JJ Naidich","year":"2020","unstructured":"Naidich, J. J. et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on imaging case volumes. J. Am. Coll. Radiol. 17(7), 865\u2013872 (2020).","journal-title":"J. Am. Coll. Radiol."},{"issue":"3","key":"7984_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(20)30743-9","volume":"22","author":"K Spencer","year":"2021","unstructured":"Spencer, K. et al. The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study. Lancet Oncol. 22(3), 309\u2013320 (2021).","journal-title":"Lancet Oncol."},{"issue":"4","key":"7984_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41416-020-01182-z","volume":"124","author":"T Gathani","year":"2021","unstructured":"Gathani, T., Clayton, G., MacInnes, E. & Horgan, K. The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020. Br. J. Cancer. 124(4), 710\u2013712 (2021).","journal-title":"Br. J. Cancer."},{"issue":"3","key":"7984_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S2468-1253(21)00005-4","volume":"6","author":"EJA Morris","year":"2021","unstructured":"Morris, E. J. A. et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol. Hepatol. 6(3), 199\u2013208 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"7984_CR23","doi-asserted-by":"crossref","unstructured":"The NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium, Eijkelboom AH, de\u00a0Munck L, Vrancken Peeters M-JTFD, Broeders MJM, Strobbe LJA, et al. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study. J. Hematol. Oncol. 14(1), 64 (2021).","DOI":"10.1186\/s13045-021-01073-7"},{"issue":"3","key":"7984_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000512935","volume":"44","author":"P Reichardt","year":"2020","unstructured":"Reichardt, P. et al. Decreased incidence of oncology admissions in 75 helios hospitals in Germany during the COVID-19 pandemic. Oncol Res Treat. 44(3), 71\u201375 (2020).","journal-title":"Oncol Res Treat."},{"issue":"6","key":"7984_CR25","doi-asserted-by":"publisher","first-page":"e001090","DOI":"10.1136\/esmoopen-2020-001090","volume":"5","author":"G Chazan","year":"2020","unstructured":"Chazan, G. et al. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. ESMO Open. 5(6), e001090 (2020).","journal-title":"ESMO Open."},{"key":"7984_CR26","unstructured":"Caisse nationale de l\u2019assurance maladie. \u00c9tude Odenore\u202f: pr\u00e8s de 2 personnes sur 3 ont renonc\u00e9 \u00e0 se soigner pendant le premier confinement [Internet]. [cit\u00e9 28 avr 2021]. Disponible sur: https:\/\/www.ameli.fr\/hauts-de-seine\/medecin\/actualites\/etude-odenore-pres-de-2-personnes-sur-3-ont-renonce-se-soigner-pendant-le-premier-confinement#?."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07984-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07984-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07984-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:17:30Z","timestamp":1669335450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07984-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7984"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-07984-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4207"}}